MNLpharma was established in June 1999 as MolecularNature. Its aim is to discover novel pharmaceutical leads and other products from plants. The company has discovered a unique family of imino sugar compounds that stimulate the immune system in a novel manner, addressing unmet clinical needs. The company has built a drug discovery engine based on its technology platform Phytoquest®. MNLpharma focuses on immunomodulation, cancer and infectious disease and the pipeline products include MNLP24, MNLP462a, MNLP1242 etc.